疑似或确诊COVID-19患者的围术期管理:回顾性队列研究与建议
该研究结合快速文献综述与武汉同济医院166例剖宫产产妇的回顾性队列分析,探讨COVID-19对围术期管理及临床结局的影响。综述发现急诊手术、大手术、术前状况差及恶性肿瘤手术与更高30天死亡率相关,区域麻醉受推荐。队列显示疑似或确诊患者手术时间、氧疗时间和住院时间更长,但新生儿结局无差异;262名使用三级防护的医护人员无一感染。
要点
- 疑似COVID-19时,非急诊手术前应考虑检测。
- 疑似或确诊患者围术期医护人员应使用三级防护。
- 疑似或确诊产妇手术时间、氧疗及住院时间延长,新生儿结局无差异。
核心结论
- 疑似COVID-19时非急诊手术前应考虑检测,医护人员围术期应使用三级防护,但防护时机与规格仍需研究。
研究设计与样本
- 快速文献综述检索EMBASE、MEDLINE、PubMed、Scopus和Web of Science(2020年1月1日至7月1日),纳入26项研究。
- 回顾性队列分析武汉同济医院COVID-19疫情期间166例剖宫产产妇,并从电子病历获取数据。
主要发现
- 综述中一项大型队列报告择期手术后诊断COVID-19的患者死亡率高于术前诊断者。
- 急诊手术、大手术、术前状况较差及恶性肿瘤手术与更高的30天死亡率相关。
- 队列中疑似或确诊患者手术时间、氧疗时间和住院时间均长于阴性患者,但新生儿结局无差异。
- 262名参与医护人员使用三级防护围术期均未感染SARS-CoV-2。
关键数值与推荐
- 疑似COVID-19时,非急诊手术前应考虑检测。
- 疑似或确诊患者围术期医护人员应使用三级防护。
临床怎么用
- 对疑似或确诊COVID-19患者,非急诊手术前考虑检测,围术期使用三级防护。
- 多数研究支持区域麻醉用于此类患者。
局限性
- 综述纳入研究主要为病例报告/系列,证据等级有限。
- 医护人员防护的使用时机和规格描述不足,需进一步研究。
- 需研究更长期结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Current guidelines for perioperative management of coronavirus disease 19 (COVID-19) are mainly based on extrapolated evidence or expert opinion. We aimed to systematically investigate how COVID-19 affects perioperative management and clinical outcomes, to develop evidence-based guidelines. METHODS: First, we conducted a rapid literature review in EMBASE, MEDLINE, PubMed, Scopus, and Web of Science (January 1 to July 1, 2020), using a predefined protocol. Second, we performed a retrospective cohort analysis of 166 women undergoing Caesarean section at Tongji Hospital, Wuhan during the COVID-19 pandemic. Demographic, imaging, laboratory, and clinical data were obtained from electronic medical records. RESULTS: The review identified 26 studies, mainly case reports/series. One large cohort reported greater mortality in elective surgery patients diagnosed after, rather than before surgery. Higher 30 day mortality was associated with emergency surgery, major surgery, poorer preoperative condition and surgery for malignancy. Regional anaesthesia was favoured in most studies and personal protective equipment (PPE) was generally used by healthcare workers (HCWs), but its use was poorly described for patients. In the retrospective cohort study, duration of surgery, oxygen therapy and hospital stay were longer in suspected or confirmed patients than negative patients, but there were no differences in neonatal outcomes. None of the 262 participating HCWs was infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) when using level 3 PPE perioperatively. CONCLUSIONS: When COVID-19 is suspected, testing should be considered before non-urgent surgery. Until further evidence is available, HCWs should use level 3 PPE perioperatively for suspected or confirmed patients, but research is needed on its timing and specifications. Further research must examine longer-term outcomes. CLINICAL TRIAL REGISTRATION: CRD42020182891 (PROSPERO).
引用
- Zheng H, Hébert HL, Chatziperi A, et al. Perioperative management of patients with suspected or confirmed COVID-19: review and recommendations for perioperative management from a retrospective cohort study. Br J Anaesth. 2020. PMID: 33121750. doi:10.1016/j.bja.2020.08.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。